Tourmaline Bio Inc
NASDAQ:TRML

Watchlist Manager
Tourmaline Bio Inc Logo
Tourmaline Bio Inc
NASDAQ:TRML
Watchlist
Price: 47.98 USD Market Closed
Market Cap: 1.2B USD

Wall Street
Price Targets

TRML Price Targets Summary
Tourmaline Bio Inc

Wall Street analysts forecast TRML stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TRML is 48.96 USD with a low forecast of 48.48 USD and a high forecast of 50.4 USD.

Lowest
Price Target
48.48 USD
1% Upside
Average
Price Target
48.96 USD
2% Upside
Highest
Price Target
50.4 USD
5% Upside
Tourmaline Bio Inc Competitors:
Price Targets
PASG
Passage Bio Inc
312% Upside
CCCC
C4 Therapeutics Inc
390% Upside
2480
Beijing Luzhu Biotechnology Co Ltd
37% Upside
BCYC
Bicycle Therapeutics PLC
196% Upside
MSB
Mesoblast Ltd
30% Upside
GLPG
Galapagos NV
9% Upside
SKYE
Skye Bioscience Inc
715% Upside
RXRX
Recursion Pharmaceuticals Inc
49% Upside

Revenue
Forecast

Revenue Estimate
Tourmaline Bio Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Tourmaline Bio Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Tourmaline Bio Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-69%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TRML's stock price target?
Price Target
48.96 USD

According to Wall Street analysts, the average 1-year price target for TRML is 48.96 USD with a low forecast of 48.48 USD and a high forecast of 50.4 USD.

Back to Top